ChemicalBook > CAS DataBase List > FIDAS-3

FIDAS-3

Product Name
FIDAS-3
CAS No.
1266684-01-8
Chemical Name
FIDAS-3
Synonyms
FIDAS-3;FIDAS-3 ,E0081;FIDAS-3, 10 mM in DMSO;Wnt Pathway Inhibitor XII;(E)-4-(2,6-Difluorostyryl)-N,N-dimethylaniline;Benzenamine, 4-[(1E)-2-(2,6-difluorophenyl)ethenyl]-N,N-dimethyl-;FIDAS-3,Inhibitor,Wnt,CyclinD1,anti-proliferation,FIDAS3,FIDAS 3,c-Myc,MAT2A,β-catenin,S-adenosylmethionine,anti-cancer,SAH,inhibit,SAM
CBNumber
CB88054403
Molecular Formula
C16H15F2N
Formula Weight
259.29
MOL File
1266684-01-8.mol
More
Less

FIDAS-3 Property

Boiling point:
355.8±30.0 °C(Predicted)
Density 
1.183±0.06 g/cm3(Predicted)
storage temp. 
4°C, protect from light
solubility 
DMSO : 100 mg/mL (385.67 mM; Need ultrasonic)
form 
A solid
pka
4.68±0.24(Predicted)
color 
off-white to pale yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

FIDAS-3 Chemical Properties,Usage,Production

Uses

FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities[1][2].

Biological Activity

FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9 μM for methionine S-adenosyltransferase 2A (MAT2A). FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding. FIDAS-3 has anticancer activities[1][2]. FIDAS-3 (3 μM; 7 days; LS174T cells) treatment significantly inhibits the proliferation of LS174T cells[1]. FIDAS-3 (3-10 μM) treatment inhibits the expression of c-Myc and cyclinD1 in LS174T CRC cells. And FIDAS-3 induces the expression of cell cycle inhibitor, p21WAF1/CIP1[1]. FIDAS-3 (10 μM; 36 h) treatment reduces the levels of both S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in LS174T cells[1]. FIDAS-3 (20 mg/kg; intraperitoneal injection; daily; for one months; C57BL/6J athymic nude mice) treatment significantly inhibits the growth of xenograft tumors[2].

in vivo

FIDAS-3 (20 mg/kg; intraperitoneal injection; daily; for one months; C57BL/6J athymic nude mice) treatment significantly inhibits the growth of xenograft tumors[2].

Animal Model:C57BL/6J athymic nude mice (6-8 week) injected with LS174 cells[2]
Dosage:20 mg/kg
Administration:Intraperitoneal injection; daily; for one months
Result:Significantly inhibited the growth of xenograft tumors.

References

[1]. Zhang W, et al. Fluorinated N,N-dialkylaminostilbenes repress colon cancer by targeting methionine S-adenosyltransferase 2A. ACS Chem Biol. 2013 Apr 19;8(4):796-803. [2]. Zhang W, et al. Fluorinated N,N-dialkylaminostilbenes for Wnt pathway inhibition and colon cancer repression. J Med Chem. 2011 Mar 10;54(5):1288-97.

FIDAS-3 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

FIDAS-3 Suppliers

TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354;
Email
support@targetmol.com
Country
United States
ProdList
39035
Advantage
58
Aladdin Scientific
Tel
Email
tp@aladdinsci.com
Country
United States
ProdList
52923
Advantage
58
Cayman Chemical Company
Tel
--
Fax
--
Email
cayman@caymanchem.com
Country
United States
ProdList
6213
Advantage
81

1266684-01-8, FIDAS-3Related Search:


  • FIDAS-3
  • FIDAS-3,Inhibitor,Wnt,CyclinD1,anti-proliferation,FIDAS3,FIDAS 3,c-Myc,MAT2A,β-catenin,S-adenosylmethionine,anti-cancer,SAH,inhibit,SAM
  • Benzenamine, 4-[(1E)-2-(2,6-difluorophenyl)ethenyl]-N,N-dimethyl-
  • (E)-4-(2,6-Difluorostyryl)-N,N-dimethylaniline
  • FIDAS-3, 10 mM in DMSO
  • Wnt Pathway Inhibitor XII
  • FIDAS-3 ,E0081
  • 1266684-01-8